Rexahn Pharmaceuticals, Inc.
Rexahn To Raise $5 Million in Registered Direct Offering
Published in Law and Health Weekly, November 7th, 2009
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage biopharmaceutical company focused on developing multi-indication therapeutics in CNS and oncology, announced it has entered into definitive agreements to sell 6,072,383 shares of its common stock at a price per share of $0.8234 pursuant to a registered direct offering to institutional investors, resulting in gross proceeds of approximately $5 million.
Investors will also receive warrants to purchase 2,125,334 shares of Rexahn Pharmaceuticals Inc.'s common stock. The warrants have an exercise price of $1.00 per share and are exercisable at any time on or after the closing date and prior to the 5 year...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- AARP Maryland
AARP Maryland Key Vote News Alert - Acacia Research Corporation
Acacia Subsidiary Enters into License Agreement with PNC Financial Services Group, Inc. - Agency for Healthcare Research & Quality
Patient Safety and Medical Liability Reform Subcommittee Meeting - AIDS Healthcare Foundation
Congress Enacts AIDS Bill to Test 5 Million; AHF Urges President Obama to Act Swiftly - American College of Physicians
ACP statement on Senate vote, S. 1776 - American Federation of Government Employees
TSA Union to Celebrate Miami TSA Workers with Friday Event - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
